Sleep disorder business RMD has enjoyed one of its major competitors, Phillips, suffering a significant product recall enabling RMD to increase its market share. Conversely, the business has struggled like many with the shortage of computer chips but this is improving at the same time Philips is likely coming to the end of its issues which is arguably creating a balanced picture.
- We have been long RMD for over a year and although it’s not cheap we can see a test of $40 into Christmas.
MM remains long and bullish RMD
Add To Hit List
